Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia

Details

Database :

OAIster

Journal :

Uy , GL , Aldoss , I , Foster , MC , Sayre , PH , Wieduwilt , MJ , Advani , AS , Godwin , JE , Arellano , ML , Sweet , KL , Emadi , A , Ravandi , F , Erba , HP , Byrne , M , Michaelis , L , Topp , MS , Vey , N , Ciceri , F , Carrabba , MG , Paolini , S , Huls , GA , Jongen - Lavrencic , M , Wermke , M , Chevallier , P , Gyan , E , Récher , C , Stiff , PJ , Pettit , KM , Löwenberg , B , Church , SE , Anderson , E , Vadakekolathu , J , Santaguida , M , Rettig , MP , Muth , J , Curtis , T , Fehr , E , Guo , K , Zhao , J , Bakkacha , O , Jacobs , K , Tran , K , Kaminker , P , Kostova , M , Bonvini , E , Walter , RB , Davidson-Moncada , JK , Rutella , S & DiPersio , JF 2021 , ' Flotetuzumab as salvage immunotherapy for refractory acute myeloid leukemia ' , Blood , vol. 137 , no. 6 , pp. 751-762 .

Notes :

application/pdf, English

Publication Type :

Electronic Resource

Accession number :

edsoai.on1481682033

Document Type :

Electronic Resource